According to Sundar Pichai on X, Google’s experimental mammography AI identified 25% more interval cancers than conventional screening while reducing clinicians’ screening workloads by an estimated 40% in studies with Imperial College London and the NHS. As reported by Nature Cancer and highlighted by Yossi Matias on X, the AI system also detected more invasive cancers and more total cases versus standard methods, indicating meaningful sensitivity gains in real-world screening settings. According to Nature Cancer, these findings suggest operational efficiencies for radiology services and potential earlier detection pathways that could improve patient outcomes and screening throughput in national programs.